These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4169706)

  • 61. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
    [No Abstract]   [Full Text] [Related]  

  • 62. [Clinical and serological studies on live attenuated rubella virus vaccines used alone and in conjugation with measles vaccines].
    Tsuji A
    Kansenshogaku Zasshi; 1970 Mar; 43(12):394-408. PubMed ID: 4987126
    [No Abstract]   [Full Text] [Related]  

  • 63. Clinical studies with virulent and attenuated mumps viruses.
    Ennis FA; Douglas RD; Hopps HE; Meyer HM; Brown ER; Hobbins TE; Biehusen FC
    Am J Epidemiol; 1969 Feb; 89(2):176-83. PubMed ID: 5765957
    [No Abstract]   [Full Text] [Related]  

  • 64. [On vaccination against measles with live and attenuated virus (Schwarz strain)].
    Monaci V; Imperato C; Battistini A; Nardi G; Grzincich GL; Bellelli E; Mazzeo G
    Ann Sclavo; 1973; 15(3):134-40. PubMed ID: 4776383
    [No Abstract]   [Full Text] [Related]  

  • 65. [Clinical immunoserological study of combined innoculation of inactivated and live measles vaccines].
    Yamazaki Y
    Nihon Shonika Gakkai Zasshi; 1969 May; 73(5):644-55. PubMed ID: 5817193
    [No Abstract]   [Full Text] [Related]  

  • 66. Field evaluation of live virus mumps vaccine.
    Sugg WC; Finger JA; Levine RH; Pagano JS
    J Pediatr; 1968 Apr; 72(4):461-6. PubMed ID: 4869563
    [No Abstract]   [Full Text] [Related]  

  • 67. Evaluation of a live attenuated mumps vaccine (Jeryl Lynn). With observations on the optimal time for testing serologic response.
    Brunell PA; Brickman A; Steinberg S
    Am J Dis Child; 1969 Sep; 118(3):435-40. PubMed ID: 5812074
    [No Abstract]   [Full Text] [Related]  

  • 68. A field trial with live attenuated mumps virus vaccine: a serological study.
    Rossier E; Meunier J; Baker F; Marchessault V
    Can J Microbiol; 1971 Jul; 17(7):929-34. PubMed ID: 5094603
    [No Abstract]   [Full Text] [Related]  

  • 69. Live attenuated mumps virus vaccine. 1. Vaccine development.
    Buynak EB; Hilleman MR
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):768-75. PubMed ID: 4163620
    [No Abstract]   [Full Text] [Related]  

  • 70. MEASLES VACCINE FIELD TRIALS IN ALASKA. I. KILLED VACCINE FOLLOWED BY LIVE ATTENUATED VACCINE AND GAMMA-GLOBULIN WITH LIVE ATTENUATED VACCINE.
    BRODY JA; MCALISTER R; EMANUEL I; ALEXANDER ER
    JAMA; 1964 Aug; 189():339-42. PubMed ID: 14160504
    [No Abstract]   [Full Text] [Related]  

  • 71. Jeryl Lynn strain live attenuated mumps virus vaccine. Durability of immunity following administration.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    JAMA; 1968 Jan; 203(1):14-8. PubMed ID: 5694077
    [No Abstract]   [Full Text] [Related]  

  • 72. OBSERVATIONS ON THE FURTHER ATTENUATION OF MEASLES VIRUS AND ON LIVE VACCINES PREPARED FROM HIGHLY ATTENUATED LINES OF VIRUS.
    CHU CM; KU YF; CHANG YH
    Chin Med J; 1964 Aug; 83():483-96. PubMed ID: 14174535
    [No Abstract]   [Full Text] [Related]  

  • 73. MEASLES VACCINATION IN INFANTS. USE OF KILLED-LIVE COMBINATIONS.
    ALEXANDER ER; BANSMER CM; HARRIS ES; GILES B; SPARKS MJ
    Am J Dis Child; 1964 Nov; 108():470-8. PubMed ID: 14208407
    [No Abstract]   [Full Text] [Related]  

  • 74. A plaque neutralization test for determining mumps antibodies.
    Ennis FA; Douglas RD; Stewart GL; Hopps HE; Meyer HM
    Proc Soc Exp Biol Med; 1968 Dec; 129(3):896-9. PubMed ID: 5725114
    [No Abstract]   [Full Text] [Related]  

  • 75. [Results of the inoculation test of measles vaccine. 3. The result of Schwarz vaccine (highly attenuated live virus vaccine)].
    Santo K
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):356-60. PubMed ID: 6070598
    [No Abstract]   [Full Text] [Related]  

  • 76. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
    KIMURA M; ISHIGURO Y
    Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296
    [No Abstract]   [Full Text] [Related]  

  • 77. [Modification of the mumps hemagglutination-inhibition antibody determination method and inoculation test of live mumps vaccine (Hoshino strain)].
    Kakihana J
    Kansenshogaku Zasshi; 1976 Apr; 50(4):145-52. PubMed ID: 824381
    [No Abstract]   [Full Text] [Related]  

  • 78. Infants' responses to live, attenuated, B level, Jeryl Lynn mumps vaccine.
    Wilkins J; Williams FF; Wehrle PF
    Am J Dis Child; 1972 Jul; 124(1):66-7. PubMed ID: 5033752
    [No Abstract]   [Full Text] [Related]  

  • 79. [Clinical serological study of combined inocculation of measles inactivated and raw vaccines. 2. KL in Kenkyukai and Arakawa inactivated vaccine and Matsumoto and Arakawa raw vaccine].
    Tanabe Y; Arai M
    Nihon Shonika Gakkai Zasshi; 1967 Apr; 71(4):425-8. PubMed ID: 6070358
    [No Abstract]   [Full Text] [Related]  

  • 80. Ineffectiveness of isolation of patients as a method of preventing the spread of mumps. Failure of the mumps skin-test antigen to predict immune status.
    Brunell PA; Brickman A; O'Hare D; Steinberg S
    N Engl J Med; 1968 Dec; 279(25):1357-61. PubMed ID: 5697527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.